RJA
DMTK

Raymond James & Associates’s DermTech, Inc. Common Stock DMTK Stock Holding History

Raymond James & Associates’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,215
Closed -$392K – 4306
2021
Q3 		$392K Sell
12,215
-4,125
-25% -$145K ﹤0.01% 3237
2021
Q2 		$679K Sell
16,340
-21,562
-57% -$886K ﹤0.01% 2857
2021
Q1 		$1.93M Buy
+37,902
New +$1.98M ﹤0.01% 2041

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Raymond James & Associates's DMTK Position: Q4 2021 in Review

Raymond James & Associates sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 12,215 shares — an estimated $392K sold.

Raymond James & Associates first reported a position in DMTK in Q1 2021 and held it in 3 quarters. The position peaked at $1.93M in Q1 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Raymond James & Associates reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 12,215 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $392K.
  • Raymond James & Associates first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Raymond James & Associates's DermTech, Inc. Common Stock position peaked at $1.93M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.